Steven Chartier
Vice President Regulatory & Clinical Affairs Read
pharmaceutical sciences
Anika Therapeutics
Netherlands
Biography
Steven Chartier joined Anika Therapeutics, Inc. as the Company’s Vice President of Regulatory and Clinical Affairs on August 28, 2017. Most recently, Steven was Vice President of Regulatory Affairs and Quality Assurance at Augmenix Inc. where he was responsible for all Regulatory and Quality functions and activities within the organization. Prior to his work at Augmenix, Steven was the Chief Operations Officer and a member of the executive management team at Pixarbio Corporation where he oversaw the development of and led all Regulatory, Quality, and Clinical programs for the organization. Steven has also held senior leadership roles at a number of other Medical Device, Life Sciences, and Pharmaceutical organizations including Infraredx, Inc., Nucryst Pharmaceuticals, Inc., and Biogen, Inc. Steven launched his career in clinical research at the Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. Steven holds a B.A. in Psychology from Saint Anselm College and has maintained a Regulatory Affairs Certification (RAC) since 2003.
Research Interest
